Pre and Post-stroke Use of Statins Improves Stroke Outcome

INTRODUCTION: Although there is sufficient evidence that HMG CoA Reductase Inhibitors reduce stroke recurrence in patients with or ischemic heart disease, it remains unclear whether they also improve outcomes given before or after stroke onset and whether such an effect is more robust with pre-strok...

Descripción completa

Detalles Bibliográficos
Autores principales: Moonis, Majaz, Kumar, Rajat, Henninger, Nils, Kane, Kevin, Fisher, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215501/
https://www.ncbi.nlm.nih.gov/pubmed/25364144
http://dx.doi.org/10.4103/0970-0218.143021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215501/
https://www.ncbi.nlm.nih.gov/pubmed/25364144
http://dx.doi.org/10.4103/0970-0218.143021

Ejemplares similares